{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:43:26Z","timestamp":1762865006192},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Oral avascular bone necrosis is an important adverse effect of chemotherapy and biphosphate therapy.<\/jats:p><jats:p><jats:bold>Objective:\u2002<\/jats:bold> To report our experience in oral avascular bone necrosis in cancer patients assigned to undergo chemotherapy.<\/jats:p><jats:p><jats:bold>Patients and methods:\u2002<\/jats:bold> Fourteen patients presenting oral avascular bone necrosis were selected from the clinical files of five Stomatological Clinics in Brazil. Clinical data as well as treatment and prognosis information were obtained from all 14 patients.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Twelve patients (86%) were submitted to biphosphonate therapy. The most important symptom was pain, present in all cases, and the mandible was the most common involved site. Most patients (79%) had their conditions managed by antibiotic therapy and surgical debridation; however complete response was achieved in only three cases (21%).<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Avascular bone necrosis is a serious oral side\u2010effect of cancer chemotherapy, particularly in patients using biphosphonates, and antibiotic therapy and surgical debridation were not able to promote complete response in most cases.<\/jats:p>","DOI":"10.1111\/j.1601-0825.2005.01130.x","type":"journal-article","created":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T14:39:23Z","timestamp":1130855963000},"page":"365-369","source":"Crossref","is-referenced-by-count":57,"title":["Oral avascular bone necrosis associated with chemotherapy and biphosphonate therapy"],"prefix":"10.1111","volume":"11","author":[{"given":"FR","family":"Pires","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1MMA","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ES","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AS","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ER","family":"Fregnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CM","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MEP","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JP","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F de A","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MA","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"OP de","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,11]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"747","article-title":"Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia","volume":"88","author":"Aric\u00f2 M","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2003.11.009"},{"key":"e_1_2_6_4_1","first-page":"2281","article-title":"Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild\u2010type and drug\u2010resistant human leukemia T\u2010cell lines","volume":"21","author":"Ayramis IA","year":"2001","journal-title":"Anticancer Res"},{"key":"e_1_2_6_5_1","first-page":"268","article-title":"Biphosphonates and avascular necrosis of the jaws","volume":"48","author":"Carter GD","year":"2003","journal-title":"Aust Dent J"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02966406"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2004.02.014"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199607)52:3<184::AID-AJH8>3.0.CO;2-P"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2002.02796.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-2391(03)00720-1"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.99.132"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2003.11.003"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/030089160308900301"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2004.02.004"},{"key":"e_1_2_6_15_1","first-page":"1080","article-title":"Pamidronate induces modifications of circulating angiogenetic factors in cancer patients","volume":"8","author":"Santini D","year":"2002","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb04795.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1754-4505.2002.tb01178.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2003.09.001"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1210\/endo.137.6.8641182","article-title":"Bisphosphonates induces osteoblasts to secret an inhibitor of osteoclast\u2010mediated resorption","volume":"137","author":"Vitt\u00e9 C","year":"1996","journal-title":"Endocrinology"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-2391(03)00328-8"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.035295"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1601-0825.2005.01130.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1601-0825.2005.01130.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T16:19:03Z","timestamp":1697041143000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1601-0825.2005.01130.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1111\/j.1601-0825.2005.01130.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1601-0825.2005.01130.x","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}